World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
63
Citations
18876
World Ranking
2684
National Ranking
50

Overview

Ola Weiland is affiliated with Karolinska University Hospital in Sweden and has extensive research experience predominantly in the field of Medicine, with a particular focus on Hepatology and Epidemiology. Their research spans several subfields including Infectious Diseases, Economics and Econometrics, and Pathology and Forensic Medicine.

The scientist has contributed to the study of liver diseases and viral infections, with a strong emphasis on Hepatitis C and Hepatitis B viruses. Their work often intersects with topics related to liver disease diagnosis, treatment, and transplantation, as well as HIV, drug use, sexual risk behaviors, and pharmaceutical economics and policy.

Notable recent publications by Ola Weiland include the following:

  • "Long-Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver-Related Outcomes" (2020, Hepatology)
  • "Significant decrease in injection risk behaviours among participants in a needle exchange programme" (2020, Infectious Diseases)
  • "Mutations Identified in the Hepatitis C Virus (HCV) Polymerase of Patients with Chronic HCV Treated with Ribavirin Cause Resistance and Affect Viral Replication Fidelity" (2020, Antimicrobial Agents and Chemotherapy)
  • "Hepatitis C elimination - Macro-elimination" (2020, Liver International)
  • "Value appropriation in hepatitis C" (2021, The European Journal of Health Economics)

The frequent co-authors working alongside Ola Weiland include:

  • Martin Kåberg
  • Rune Wejstål
  • Soo Aleman
  • Magdalena Ydreborg
  • Peter Lindgren

Among the publication venues where Ola Weiland most frequently appears are:

  • Hepatology
  • Infectious Diseases
  • Scandinavian Journal of Gastroenterology
  • Antimicrobial Agents and Chemotherapy
  • Liver International

Their research covers key topics such as:

  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • HIV, Drug Use, Sexual Risk
  • Pharmaceutical Economics and Policy
  • HIV/AIDS Research and Interventions

Best Publications

  • Telaprevir for retreatment of HCV infection.

    Stefan Zeuzem;Pietro Andreone;Stanislas Pol;Eric Lawitz

  • Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

    Jordan J. Feld;Kris V. Kowdley;Eoin Coakley;Samuel Sigal

  • Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3

    Stefan Zeuzem;Geoffrey M. Dusheiko;Riina Salupere;Alessandra Mangia

  • Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C

    Olle Reichard;Gunnar Norkrans;Aril Frydén;Jean-Henrik Braconier

  • Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia.

    Stefan Zeuzem;Maria Buti;Peter Ferenci;Jan Sperl

  • Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.

    Alfredo Alberti;Nathan Clumeck;Simon Collins;Wolfram Gerlich

  • ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection

    Pietro Andreone;Massimo G. Colombo;Jeffrey V. Enejosa;Iftihar Koksal

  • Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

    Geoffrey Dusheiko;Janice Main;Howard Thomas;Olle Reichard

  • Ribavirin treatment for chronic hepatitis C.

    O. Reichard;J. Andersson;R. Schvarcz;O. Weiland

  • The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

    Catharina Hultgren;David R. Milich;Ola Weiland;Matti Sällberg

  • Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication

    Adriaan J. van der Meer;Jordan J. Feld;Harald Hofer;Piero L. Almasio

  • Epidemiology and the initial presentation of autoimmune hepatitis in Sweden : A nationwide study

    Mårten Werner;Hanne Prytz;Bodil Ohlsson;Sven Almer

  • A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C–Associated Liver Cirrhosis

    Soo Aleman;Nogol Rahbin;Ola Weiland;Loa Davidsdottir

  • Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study

    Pierre Pradat;Alfredo Alberti;Thierry Poynard;Juan Ignacio Esteban

  • Telaprevir alone or with peginterferon and ribavirin reduces HCV RNA in patients with chronic genotype 2 but not genotype 3 infections.

    Graham R. Foster;Christophe Hézode;Jean–Pierre Bronowicki;Giampiero Carosi

  • Limited humoral immunity in hepatitis C virus infection.

    Margaret Chen;Matti Sällberg;Anders Sönnerborg;Ola Weiland

  • Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

    Tania Mara Welzel;Jörg Petersen;Kerstin Herzer;Peter Ferenci

  • High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-α2b for 60 weeks

    Olle Reichard;Ulla Foberg;Aril Frydén;Lars Mattsson

  • Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon

    Olle Reichard;Hans Glaumann;Aril Frydén;Gunnar Norkrans

  • Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials

    Solko W. Schalm;Ola Weiland;Bettina E. Hansen;Michele Milella

  • Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy

    Bart Veldt;G. Saracco;N. Boyer;C. Camma

Frequent Co-Authors

Gunnar Norkrans
Gunnar Norkrans University of Gothenburg
Anders Sönnerborg
Anders Sönnerborg Karolinska Institute
Peter Ferenci
Peter Ferenci Medical University of Vienna
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
David R. Milich
David R. Milich Scripps Health
Graham R. Foster
Graham R. Foster Queen Mary University of London
Christophe Hézode
Christophe Hézode Université Paris Cité
Ulrich Spengler
Ulrich Spengler University of Bonn
George Klein
George Klein Karolinska Institute
Joakim Lundeberg
Joakim Lundeberg Royal Institute of Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open doors to diverse career opportunities in the healthcare and research fields. Programs such as the online cahiim accredited health information management degree provide valuable skills in managing medical data, an essential aspect of clinical research and laboratory settings.

For those seeking quicker entry into healthcare administration, the best fastest online medical billing and coding certificate programs offer certification pathways that can complement a background in microbiology by enhancing knowledge of healthcare documentation and reimbursement processes.

While traditional medical degrees often require in-person training, several options exist for remote learning. Exploring what medical degree can i get online reveals options that blend clinical knowledge with flexible study formats, ideal for working professionals aiming to expand their qualifications in health sciences.

Additionally, advanced public health education through which online mph programs are easiest to get into can equip microbiology graduates with skills in epidemiology and health policy, further broadening their career pathways in research, public health, and healthcare management.

Best Scientists Citing Ola Weiland

Trending Scientists